Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. - Wikidata - awgldk - TriplyDB

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

http://www.wikidata.org/entity/Q37234205

about

Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS Interventions for HIV-associated nephropathy Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS Therapeutic drug monitoring of antiretrovirals for people with HIV Efavirenz versus nevirapine as a non-nucleoside reverse transcriptase inhibitor in initial combination antiretroviral therapy for HIV infection Interventions for HIV-associated nephropathy Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients The HIV antiretroviral drug efavirenz has LSD-like properties Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of HIV-1 Protease Inhibitors Incorporating Phenyloxazolidinones HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy An assay to monitor HIV-1 protease activity for the identification of novel inhibitors in T-cells Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada Timing the emergence of resistance to anti-HIV drugs with large genetic barriers Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazole Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa Development and validation of a composite programmatic assessment tool for HIV therapy Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010)Incidence and predictors of first line antiretroviral regimen modification in western Kenya Development, validation and clinical evaluation of a low cost in-house HIV-1 drug resistance genotyping assay for Indian patients Estimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling Analysis Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006 Challenges in initiating antiretroviral therapy in 2010.A contact-imaging based microfluidic cytometer with machine-learning for single-frame super-resolution processing Lensless imaging for point-of-care testing.

P2860

Q24200188-08728112-4C08-4802-AC73-1478F587E3FB Q24201629-D1AE6048-E23C-443B-A61A-40AE56789DBD Q24235724-B4F87AA6-384F-41FB-9C37-BB3039CFF7DD Q24236739-92AA8EE6-F26C-4507-BEE2-1931AA363208 Q24239831-B27C663D-7A19-47C5-A5A9-01533C59AD87 Q24239932-C4AF10E8-BF25-4061-8DF6-EBEE2CDD3B3C Q24240224-3DE5F2D5-CA59-4D78-AB88-90EC869934AD Q24240525-344B5CBD-DDD9-4175-86F1-423730FFC2DD Q24241255-900110F4-8C95-48C5-9FCF-C83601FCC54C Q24606937-1FB3C00F-F82C-4182-AFD6-71804E30A517 Q24608183-A75E7457-9D23-41A2-899D-275B21877F8C Q24648578-B66F8F90-CDD7-48A8-9E49-F2A9F16A6540 Q24656950-E8FE6279-E078-4960-9D5E-7239AE859856 Q26824585-6BFA293E-4B1B-409F-B2E0-F353DF2FD47E Q27009523-AA84DCD4-FF02-4D7D-A707-0407DB178BAD Q27314576-C8D9223A-3D1D-4168-963B-A477DBA4447C Q27488274-EBA74794-B389-44EE-AD6D-F9D158D94536 Q27491355-CFC7051A-C769-4726-87D9-BFE6B22CC3CE Q27665164-BD00F7CF-53C9-4C10-B3A2-E8380B804B92 Q27666355-EF644276-4D41-4B58-B64E-0C207B53B503 Q28246329-C3BA134D-87A6-450E-A623-826C0F14017C Q28473854-15D5D706-D21F-4868-B0B8-CE64F004DDF2 Q28474218-50CBAFC5-D944-4670-8F69-1B0EDB4519BE Q28474271-1FF52257-A1F0-4EC9-AF1E-370ABBE6C179 Q28474857-12CEBFAC-BF43-48F9-B6CF-B39F3B03398A Q28477256-60EC61FE-8CCA-4F70-BE22-E302DC94FD6B Q28477379-494B76C5-6D45-4E0C-BABA-E2DD0C988F0E Q28485260-5004AEA6-DF62-43D1-9C69-37F6817E45D1 Q28539563-79E64C7B-8C80-4B7B-A385-201D378D9221 Q28541096-3261DB06-83CD-4DF5-AD44-2DCB5841BD85 Q28541822-7F8A3976-5B1E-4934-A713-843B5DEEF720 Q28542561-092C7602-AD38-40F7-8DA4-C5ED50E7D559 Q28547154-6C8B6F79-8305-4DE8-92AE-4E63C531DD03 Q28547224-6FA4380F-A031-4AF7-AABF-DE1E50F0C73F Q28610686-3B832B41-B6D6-4D16-9CE8-F8006EB8B52B Q28730855-6709BFBC-4AC4-498D-A6BA-EB9A8C316A3B Q28744286-85A9F96A-C5A5-4851-9C34-7187DDF68BF3 Q30227046-D0316A6C-7AAB-4300-8E57-1A89F322AA43 Q30433105-4B4F51D8-98D6-40E8-8680-EE7CFC0270DF Q30449272-A3B5CE7A-C91E-4C82-8C96-94E50BE02B8A

P2860

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

http://www.wikidata.org/entity/Q37234205

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antiretroviral treatment of ad ...... tional AIDS Society-USA panel.

@en

Antiretroviral treatment of ad ...... tional AIDS Society-USA panel.

@nl

type

label

Antiretroviral treatment of ad ...... tional AIDS Society-USA panel.

@en

Antiretroviral treatment of ad ...... tional AIDS Society-USA panel.

@nl

prefLabel

Antiretroviral treatment of ad ...... tional AIDS Society-USA panel.

@en

Antiretroviral treatment of ad ...... tional AIDS Society-USA panel.

@nl

P1433

Q37234205-6CF3E480-8107-4D7C-8399-D091F1EECA71

P1476

Q37234205-92898842-7A56-4925-815D-E2E0DD34B05B

P2093

Q37234205-1B985649-3D73-4E46-9DED-4214767DC9BB

Q37234205-1C70952C-57E5-4F88-98E3-AAFAACBFADAB

Q37234205-418BE117-4334-4C2E-896E-3E5AC693C366

Q37234205-545B16A9-07DC-4779-950D-B04EEED88AE4

Q37234205-5AA7DCE0-9F26-4F80-AFE3-CFCF47926F42

Q37234205-6589D3B3-062B-44F0-BD58-7F3EA5CA6DAB

Q37234205-6C9D04D3-FF9F-467A-9446-49E7C518811F

Q37234205-8C0A4618-2EF6-4263-AE8A-1060A39EFA37

Q37234205-A522DC0D-A2DE-4E55-A1C7-B61B1ACD4928

Q37234205-A86F2B42-479B-4808-A82F-8C64E2BAE67B

P304

Q37234205-C465427E-4F62-4E63-8F3E-3C9B92FA314B

P31

Q37234205-5B9ED655-060C-4E05-9E35-0ED5EEEDCFFA

P356

Q37234205-812374F5-21F2-42E3-A3FD-6D212182271B

P407

Q37234205-35D30F46-7C29-4814-8C9E-4CAB0286C279

P433

Q37234205-D6D1F560-97E8-4998-AF17-1A14E32D0DEE

P478

Q37234205-107EBFA3-A3C9-4C53-85BD-491396DA6F43

P50

Q37234205-10ECDEAE-20E2-492D-96F7-CDBD43CD6CF1

Q37234205-BC60A913-54D7-44BE-B59C-A842731BEFD2

P577

Q37234205-05F9EA5F-60C0-4CF9-A4E0-01903CE91BB8

P5875

Q37234205-52A1E543-8423-4ADD-BC79-B64C8EAFBA22

P698

Q37234205-85CC4BEF-363F-4915-97A0-8C322F8F063F

P921

Q37234205-058691E8-F477-45A7-8808-1DFE255248AA

Q37234205-5E8FB384-6702-4CEE-8BDA-01CEA84D8F17

Q37234205-BBF7743B-2854-4D9C-9C70-B14986BF75D4

P356

P1433

Journal of the American Medical Association

P1476

Antiretroviral treatment of ad ...... tional AIDS Society-USA panel.

@en

P2093

Donna M Jacobsen

http://www.w3.org/2001/XMLSchema#string

Douglas D Richman

http://www.w3.org/2001/XMLSchema#string

International AIDS Society-USA

http://www.w3.org/2001/XMLSchema#string

Jose M Gatell

http://www.w3.org/2001/XMLSchema#string

Margaret A Fischl

http://www.w3.org/2001/XMLSchema#string

Martin S Hirsch

http://www.w3.org/2001/XMLSchema#string

Melanie A Thompson

http://www.w3.org/2001/XMLSchema#string

Patrick G Yeni

http://www.w3.org/2001/XMLSchema#string

Paul A Volberding

http://www.w3.org/2001/XMLSchema#string

Pedro Cahn

http://www.w3.org/2001/XMLSchema#string

P304

555-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.300.5.555

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

300

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23146330

http://www.w3.org/2001/XMLSchema#string

P698

18677028

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug